CS1
Showing 1 - 25 of 7,907
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Not yet recruiting
- Parkinson Disease
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2023
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Pulmonary Arterial Hypertension Trial in Gothenburg (CS1 Administration)
Recruiting
- Pulmonary Arterial Hypertension
- CS1 Administration
-
Gothenburg, SwedenNiklas Bergh
Dec 5, 2022
Multiple Myeloma Trial in Charlottesville (SLAMF7 BATs)
Not yet recruiting
- Multiple Myeloma
- SLAMF7 BATs
-
Charlottesville, VirginiaUniversity of Virginia
May 17, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (CS1-CAR T Therapy, Cyclophosphamide, Fludarabine)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- CS1-CAR T Therapy
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 15, 2021
CS1+ or BCMA+ Multiple Myeloma Trial in Wuhan (Conditioning chemo followed by CAR T cell infusion)
Recruiting
- CS1+ or BCMA+ Multiple Myeloma
- Conditioning chemotherapy followed by CAR T cell infusion
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Feb 11, 2022
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
HIV Trial in Nampula (Radio Ads, Community Sensitization Campaign, Informational Posters)
Recruiting
- HIV
- Radio Ads
- +13 more
-
Nampula, Mozambique
- +11 more
Oct 13, 2022
EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up
Recruiting
- Joint Diseases
- EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert
-
Milan, Piazza C. Ferrari 1 20122 Milan, ItalyGaetano Pini Orthopedic Institute
Nov 16, 2023
Healthy Trial in Shanghai (CS12192 capsule, Placebo capsule)
Not yet recruiting
- Healthy
- CS12192 capsule
- Placebo capsule
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Jun 27, 2023
Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)
Not yet recruiting
- Alzheimer's Disease
- CS6253 Solution for Injection
- Placebo
- (no location specified)
Jul 20, 2023
Relapsed/Refractory Multiple Myeloma Trial in United States (UCARTCS1A)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- UCARTCS1A
-
San Francisco, California
- +4 more
Nov 11, 2021
Cardiac Disease, Myocardial Dysfunction Trial in Oslo (CS1 System)
Enrolling by invitation
- Cardiac Disease
- Myocardial Dysfunction
- CS1 System
-
Oslo, NorwayOslo University Hospital
Nov 9, 2021
DM1, Muscular Dystrophies, Myotonic Dystrophy Trial in United States (Placebo, AOC 1001)
Enrolling by invitation
- DM1
- +12 more
- Placebo
- AOC 1001
-
Los Angeles, California
- +7 more
Jul 27, 2022
Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 5, 2023
Relapse Multiple Myeloma Trial in Hangzhou (CS1 Targeted CAR T-cells)
Not yet recruiting
- Relapse Multiple Myeloma
- CS1 Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Dec 9, 2020
Healthy Trial in Barcelona, Madrid, Sevilla (Nutribén Innova® 1, Nutribén®, Breastfeed)
Completed
- Healthy
- Nutribén Innova® 1
- +2 more
-
Barcelona, Spain
- +20 more
Mar 30, 2022
Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
Active, not recruiting
- Multiple System Atrophy
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Mar 8, 2022
Advanced Cancer Trial in Randwick (CS1003, Regorafenib)
Completed
- Advanced Cancer
- CS1003
- Regorafenib
-
Randwick, New South Wales, AustraliaScientia Clinical Research Ltd
Feb 17, 2022